ROYCE & ASSOCIATES LP - AQUINOX PHARMACEUTICALS INC ownership

AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 25 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of AQUINOX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$343,000
-12.5%
145,3970.0%0.00%0.0%
Q1 2019$392,000
+24.8%
145,3970.0%0.00%0.0%
Q4 2018$314,000
-26.3%
145,3970.0%0.00%0.0%
Q3 2018$426,000
+10.6%
145,3970.0%0.00%0.0%
Q2 2018$385,000
-81.2%
145,3970.0%0.00%
-78.6%
Q1 2018$2,047,000
+19.7%
145,3970.0%0.01%
+27.3%
Q4 2017$1,710,000
-17.1%
145,3970.0%0.01%
-21.4%
Q3 2017$2,063,000
+0.8%
145,3970.0%0.01%0.0%
Q2 2017$2,046,000
-15.7%
145,3970.0%0.01%
-12.5%
Q1 2017$2,427,000
-7.8%
145,397
-8.8%
0.02%
-5.9%
Q4 2016$2,633,000
+21.2%
159,497
-1.9%
0.02%
+21.4%
Q3 2016$2,173,000
+79.7%
162,622
-11.0%
0.01%
+75.0%
Q2 2016$1,209,000
+42.6%
182,622
+89.9%
0.01%
+60.0%
Q1 2016$848,000
+265.5%
96,167
+416.4%
0.01%
+400.0%
Q4 2015$232,000
-11.5%
18,6220.0%0.00%0.0%
Q3 2015$262,000
-66.5%
18,622
-83.5%
0.00%
-66.7%
Q2 2015$783,000
-19.1%
112,8540.0%0.00%
-25.0%
Q1 2015$968,000
-1.0%
112,854
-13.5%
0.00%
+33.3%
Q4 2014$978,000
+75.3%
130,454
+55.8%
0.00%
+50.0%
Q3 2014$558,00083,7320.00%
Other shareholders
AQUINOX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Prosight Management, LP 400,900$1,062,0000.78%
EMORY UNIVERSITY 209,207$554,0000.37%
EcoR1 Capital, LLC 1,150,000$3,048,0000.29%
Baker Brothers Advisors 10,934,154$28,976,0000.22%
DLD Asset Management, LP 763,100$2,030,0000.15%
UNIVERSITY OF NOTRE DAME DU LAC 214,759$569,0000.11%
Kalos Management, Inc. 15,850$226,0000.10%
SPHERA FUNDS MANAGEMENT LTD. 257,613$683,0000.09%
DLD Asset Management, LP 379,900$1,007,0000.08%
DLD Asset Management, LP 379,300$1,009,0000.08%
View complete list of AQUINOX PHARMACEUTICALS INC shareholders